Rybelsus alternatives.

10 compounds compared to Rybelsus, ranked by published evidence tier and regulatory status, not by what's marketed hardest.

Rybelsus is a brand name for oral semaglutide. The alternatives below are compared to that molecule.

Why people look for an alternative

Semaglutide alternatives get searched for reasons that have nothing to do with whether the drug works. It is one of the most extensively studied peptide therapeutics in modern medicine, with dedicated cardiovascular and liver outcome trials, and it is fully approved as Ozempic and Rybelsus for type 2 diabetes and Wegovy for chronic weight management and cardiovascular risk reduction. What sends people looking is cost, an insurance denial, supply, gastrointestinal side effects they cannot tolerate, or the opposite problem of wanting more effect than they are getting. Those four motivations point in different directions: a different incretin drug, a different receptor combination, or a conversation about coverage rather than chemistry.

What you're comparing against
Semaglutide
S tier · 95/100FDA-approved

Semaglutide is a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist, an acylated, structurally modified analog of the native incretin hormone GLP-1, engineered for once-weekly (injectable) or daily (oral) dosing through albumin binding and resistance to DPP-4 degradation.

Ranked by evidence · strongest first
  1. 01
    Liraglutide
    S tierFDA-approved
    Victoza · Saxenda

    Acts through the glp-1 receptor agonism pathway, like Semaglutide. FDA-approved.

  2. 02
    Tirzepatide
    S tierFDA-approved
    Mounjaro · Zepbound

    Acts through the glp-1 receptor agonism pathway, like Semaglutide. FDA-approved.

  3. 03
    Survodutide
    B tierIn human trials
    BI 456906

    Acts through the glp-1 receptor agonism pathway, like Semaglutide. In human trials.

  4. 04
    Mazdutide
    B tierIn human trials
    IBI362 · LY3305677

    Acts through the glp-1 receptor agonism pathway, like Semaglutide. In human trials.

  5. 05
    Retatrutide
    B tierIn human trials
    triple agonist

    Acts through the glp-1 receptor agonism pathway, like Semaglutide. In human trials.

  6. 06
    CagriSema
    C tierIn human trials
    cagrilintide + semaglutide

    Acts through the glp-1 receptor agonism pathway, like Semaglutide. In human trials.

  7. 07
    Cagrilintide
    C tierIn human trials
    amylin analog

    Same category: metabolic & glp-1. In human trials.

  8. 08
    AOD-9604
    D tierResearch / preclinical

    Same category: metabolic & glp-1. Research / preclinical.

  9. 09
    HGH Fragment 176-191
    F tierResearch / preclinical
    hGH frag 176-191 · GH lipolytic fragment

    Same category: metabolic & glp-1. Research / preclinical.

  10. 10
    Adipotide
    F tierResearch / preclinical
    FTPP

    Same category: metabolic & glp-1. Research / preclinical.

How this list is built

An “alternative” here means a compound that shares Semaglutide's mechanism pathway or sits in the same category, not a marketing substitute. Each is ordered by PepCue's evidence tier (a weighted 0–100 score across human data, safety, replication and regulatory clarity), then by whether it's actually approved. This is a research reference, not medical or purchasing advice: an alternative sitting higher on evidence does not mean it's right, safe, or legal for any given use. Reviewed June 1, 2026.

Comparing options with your provider?

PepCue keeps every compound, dose and lab in one private, provider-ready timeline, whichever one you land on.

Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page
Compounds